{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:30:18Z","timestamp":1789695018863,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Distinguishing arginine vasopressin (AVP) deficiency (central diabetes insipidus) from primary polydipsia is challenging. While hypertonic saline-stimulated copeptin testing provides the highest diagnostic accuracy, it is often restricted to specialised centres, requiring close monitoring and potentially causing patient discomfort. Initially, arginine-stimulated copeptin was proposed as a simpler alternative, but a head-to-head comparison study found it less precise than hypertonic saline stimulation. However, the same study identified two new high sensitivity and specificity cut-offs for arginine-stimulated copeptin, though these cut-offs have yet to be validated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a secondary post-hoc analysis of the initial prospective multicentre study, including adult patients with confirmed AVP deficiency or primary polydipsia. Participants underwent the arginine stimulation test, with plasma copeptin measured at baseline and 60- and 90\u00a0min after arginine infusion. The primary objective was to revisit the original study to internally validate the proposed arginine-stimulated copeptin cut-offs of &gt;\u20095.2pmol\/L (high specificity cut-off with &gt;\u200990% specificity for primary polydipsia) and \u2264\u20093.0 pmol\/L (high specificity cut-off with &gt;\u200990% specificity for AVP deficiency).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>In total, 96 patients were included between May 2013 and June 2018: <jats:italic>n<\/jats:italic>\u2009=\u200938 [40%] with AVP deficiency and <jats:italic>n<\/jats:italic>\u2009=\u200958 [60%] with primary polydipsia. At 60\u00a0min after arginine infusion, a copeptin level\u2009\u2264\u20093.0 pmol\/L showed a specificity of 95% (95% CI: 0.88-1.00) for AVP deficiency, while a copeptin level\u2009&gt;\u20095.2 pmol\/L demonstrated a specificity of 97% (95% CI: 0.92-1.00) for primary polydipsia. The \u2264\u20093.0 pmol\/L cut-off accurately identified 71% (<jats:italic>n<\/jats:italic>\u2009=\u200927\/38) of patients with AVP deficiency, and the &gt;\u20095.2 pmol\/L cut-off correctly identified 69% (<jats:italic>n<\/jats:italic>\u2009=\u200940\/58) of patients with primary polydipsia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation<\/jats:title>\n            <jats:p>This analysis validates two new copeptin cut-offs of the arginine stimulation test to distinguish AVP deficiency from primary polydipsia: &gt;5.2 pmol\/L for high specificity in diagnosing primary polydipsia and \u2264\u20093.0 pmol\/L for high specificity in diagnosing AVP deficiency. These thresholds might offer a practical initial alternative to hypertonic saline testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration<\/jats:title>\n            <jats:p>Clinicaltrials.gov (NCT00757276).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11102-025-01523-2","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T23:59:38Z","timestamp":1745625578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)"],"prefix":"10.1007","volume":"28","author":[{"given":"Cihan","family":"Atila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Chifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Refardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"publisher","unstructured":"Atila C, Refardt J, Christ-Crain M (2024) Arginine vasopressin deficiency: diagnosis, management and the relevance of Oxytocin deficiency. Nat Rev Endocrinol May 1. https:\/\/doi.org\/10.1038\/s41574-024-00985-x","DOI":"10.1038\/s41574-024-00985-x"},{"issue":"10","key":"1523_CR2","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1210\/clinem\/dgac381","volume":"28","author":"M Tomkins","year":"2022","unstructured":"Tomkins M, Lawless S, Martin-Grace J, Sherlock M, Thompson CJ (2022) Diagnosis and management of central diabetes insipidus in adults. J Clin Endocrinol Metab Sep 28(10):2701\u20132715. https:\/\/doi.org\/10.1210\/clinem\/dgac381","journal-title":"J Clin Endocrinol Metab Sep"},{"issue":"1","key":"1523_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41572-019-0103-2","volume":"8","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain M, Bichet DG, Fenske WK et al (2019) Diabetes insipidus. Nat Rev Dis Primers Aug 8(1):54. https:\/\/doi.org\/10.1038\/s41572-019-0103-2","journal-title":"Nat Rev Dis Primers Aug"},{"key":"1523_CR4","doi-asserted-by":"publisher","unstructured":"Dilrukshi M, Vickars M, May C et al (Jul. 2022) Management of cranial diabetes Insipidus\u2013 clinical outcomes and patient perception of care. Eur J Endocrinol 01:2022:EJE\u201322. https:\/\/doi.org\/10.1530\/eje-22-0187","DOI":"10.1530\/eje-22-0187"},{"issue":"5","key":"1523_CR5","doi-asserted-by":"publisher","first-page":"101385","DOI":"10.1016\/j.beem.2020.101385","volume":"34","author":"A Garrahy","year":"2020","unstructured":"Garrahy A, Thompson CJ (2020) Management of central diabetes insipidus. Best Pract Res Clin Endocrinol Metab Sep 34(5):101385. https:\/\/doi.org\/10.1016\/j.beem.2020.101385","journal-title":"Best Pract Res Clin Endocrinol Metab Sep"},{"issue":"5","key":"1523_CR6","doi-asserted-by":"publisher","first-page":"101469","DOI":"10.1016\/j.beem.2020.101469","volume":"34","author":"L Ahmadi","year":"2020","unstructured":"Ahmadi L, Goldman MB (2020) Primary polydipsia: update. Best Pract Res Clin Endocrinol Metab Sep 34(5):101469. https:\/\/doi.org\/10.1016\/j.beem.2020.101469","journal-title":"Best Pract Res Clin Endocrinol Metab Sep"},{"issue":"1","key":"1523_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.33176\/aacb-20-00001","volume":"42","author":"R Jalleh","year":"2021","unstructured":"Jalleh R, Torpy DJ (2021) The emerging role of copeptin. Clin Biochem Rev Feb 42(1):17\u201325. https:\/\/doi.org\/10.33176\/aacb-20-00001","journal-title":"Clin Biochem Rev Feb"},{"issue":"3","key":"1523_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11154-019-09509-9","volume":"20","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain M (2019) Vasopressin and copeptin in health and disease. Rev Endocr Metab Disord Sep 20(3):283\u2013294. https:\/\/doi.org\/10.1007\/s11154-019-09509-9","journal-title":"Rev Endocr Metab Disord Sep"},{"issue":"1","key":"1523_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/cen.13991","volume":"91","author":"J Refardt","year":"2019","unstructured":"Refardt J, Winzeler B, Christ-Crain M (2019) Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. Clin Endocrinol (Oxf) Jul 91(1):22\u201332. https:\/\/doi.org\/10.1111\/cen.13991","journal-title":"Clin Endocrinol (Oxf) Jul"},{"issue":"4","key":"1523_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/joim.12645","volume":"282","author":"L Bankir","year":"2017","unstructured":"Bankir L, Bichet DG, Morgenthaler NG (2017) Vasopressin: physiology, assessment and osmosensation. J Intern Med Oct 282(4):284\u2013297. https:\/\/doi.org\/10.1111\/joim.12645","journal-title":"J Intern Med Oct"},{"key":"1523_CR11","doi-asserted-by":"publisher","unstructured":"Mu D, Ma Y, Cheng J, Qiu L, Chen S, Cheng X (2023) Diagnostic accuracy of copeptin in the differential diagnosis of patients with diabetes insipidus: A systematic review and Meta-analysis. Endocr Pract May 22. https:\/\/doi.org\/10.1016\/j.eprac.2023.05.006","DOI":"10.1016\/j.eprac.2023.05.006"},{"issue":"20","key":"1523_CR12","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa2306263","volume":"16","author":"J Refardt","year":"2023","unstructured":"Refardt J, Atila C, Chifu I et al (2023) Arginine or hypertonic Saline-Stimulated copeptin to diagnose AVP deficiency. N Engl J Med Nov 16(20):1877\u20131887. https:\/\/doi.org\/10.1056\/NEJMoa2306263","journal-title":"N Engl J Med Nov"},{"key":"1523_CR13","doi-asserted-by":"publisher","unstructured":"Christ-Crain M, Winzeler B, Refardt J (Jul 2021) Diagnosis and management of diabetes insipidus for the internist: an update. J Intern Med 290(1):73\u201387. https:\/\/doi.org\/10.1111\/joim.13261","DOI":"10.1111\/joim.13261"},{"key":"1523_CR14","doi-asserted-by":"publisher","first-page":"w20237","DOI":"10.4414\/smw.2020.20237","volume":"4","author":"J Refardt","year":"2020","unstructured":"Refardt J, Christ-Crain M (2020) Copeptin-based diagnosis of diabetes insipidus. Swiss Med Wkly May 4:150:w20237. https:\/\/doi.org\/10.4414\/smw.2020.20237","journal-title":"Swiss Med Wkly May"},{"issue":"5","key":"1523_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1803760","volume":"2","author":"W Fenske","year":"2018","unstructured":"Fenske W, Refardt J, Chifu I et al (2018) A Copeptin-Based approach in the diagnosis of diabetes insipidus. N Engl J Med Aug 2(5):428\u2013439. https:\/\/doi.org\/10.1056\/NEJMoa1803760","journal-title":"N Engl J Med Aug"},{"issue":"10198","key":"1523_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/s0140-6736(19)31255-3","volume":"17","author":"B Winzeler","year":"2019","unstructured":"Winzeler B, Cesana-Nigro N, Refardt J et al (2019) Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Lancet Aug 17(10198):587\u2013595. https:\/\/doi.org\/10.1016\/s0140-6736(19)31255-3","journal-title":"Lancet Aug"},{"issue":"5","key":"1523_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jamainternmed.2020.0045","volume":"1","author":"AS Levey","year":"2020","unstructured":"Levey AS, Tighiouart H, Titan SM, Inker LA (2020) Estimation of glomerular filtration rate with vs without including patient race. JAMA Intern Med May 1(5):793\u2013795. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0045","journal-title":"JAMA Intern Med"},{"key":"1523_CR18","unstructured":"Core Team R (2021) R: A Language and environment for statistical computing. R Foundation Stat Comput Vienna Austria. https:\/\/www.r-project.org\/"},{"key":"1523_CR19","doi-asserted-by":"publisher","unstructured":"Atila C, Loughrey PB, Garrahy A et al (2022) Central diabetes insipidus from a patient\u2019s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes Endocrinol Aug 22. https:\/\/doi.org\/10.1016\/s2213-8587(22)00219-4","DOI":"10.1016\/s2213-8587(22)00219-4"},{"issue":"14","key":"1523_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/nejm200010053431403","volume":"5","author":"M Maghnie","year":"2000","unstructured":"Maghnie M, Cosi G, Genovese E et al (2000) Central diabetes insipidus in children and young adults. N Engl J Med Oct 5(14):998\u20131007. https:\/\/doi.org\/10.1056\/nejm200010053431403","journal-title":"N Engl J Med"},{"key":"1523_CR21","doi-asserted-by":"publisher","unstructured":"Fenske W, Quinkler M, Lorenz D et al (May 2011) Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome\u2013revisiting the direct and indirect water deprivation tests. J Clin Endocrinol Metab 96(5):1506\u20131515. https:\/\/doi.org\/10.1210\/jc.2010-2345","DOI":"10.1210\/jc.2010-2345"},{"issue":"10","key":"1523_CR22","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/jc.2012-1981","volume":"97","author":"W Fenske","year":"2012","unstructured":"Fenske W, Allolio B (2012) Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab Oct 97(10):3426\u20133437. https:\/\/doi.org\/10.1210\/jc.2012-1981","journal-title":"J Clin Endocrinol Metab Oct"},{"issue":"4","key":"1523_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/cen.14880","volume":"98","author":"G Binder","year":"2023","unstructured":"Binder G, Weber K, Peter A, Schweizer R (2023) Arginine-stimulated copeptin in children and adolescents. Clin Endocrinol (Oxf) Apr 98(4):548\u2013553. https:\/\/doi.org\/10.1111\/cen.14880","journal-title":"Clin Endocrinol (Oxf) Apr"},{"key":"1523_CR24","doi-asserted-by":"publisher","unstructured":"Atila C, Monnerat S, Urwyler SA, Refardt J, Winzeler B, Christ-Crain M (2022) The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and Macimorelin stimulation in healthy adults: data from: glucacop, Macicop, and CARGO study. Pituit Jun 20. https:\/\/doi.org\/10.1007\/s11102-022-01240-0","DOI":"10.1007\/s11102-022-01240-0"},{"issue":"1","key":"1523_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11154-020-09594-1","volume":"22","author":"NA Tritos","year":"2021","unstructured":"Tritos NA, Biller BMK (2021) Current concepts of the diagnosis of adult growth hormone deficiency. Rev Endocr Metab Disord Mar 22(1):109\u2013116. https:\/\/doi.org\/10.1007\/s11154-020-09594-1","journal-title":"Rev Endocr Metab Disord Mar"},{"key":"1523_CR26","doi-asserted-by":"publisher","first-page":"608056","DOI":"10.5402\/2011\/608056","volume":"2011","author":"KC Yuen","year":"2011","unstructured":"Yuen KC (2011) Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives. ISRN Endocrinol 2011:608056. https:\/\/doi.org\/10.5402\/2011\/608056","journal-title":"ISRN Endocrinol"},{"issue":"4","key":"1523_CR27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1210\/jcem.79.4.7962300","volume":"79","author":"G Mastorakos","year":"1994","unstructured":"Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP (1994) Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by Recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab Oct 79(4):934\u2013939. https:\/\/doi.org\/10.1210\/jcem.79.4.7962300","journal-title":"J Clin Endocrinol Metab Oct"},{"issue":"4","key":"1523_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000528661","volume":"96","author":"CA March","year":"2023","unstructured":"March CA, Sastry S, McPhaul MJ, Wheeler SE, Garibaldi L (2023) Combined arginine and insulin stimulation elicits a robust and consistent copeptin response in short children. Horm Res Paediatr 96(4):395\u2013403. https:\/\/doi.org\/10.1159\/000528661","journal-title":"Horm Res Paediatr"},{"key":"1523_CR29","doi-asserted-by":"publisher","unstructured":"March CA, Sastry S, McPhaul MJ, Wheeler SE, Garibaldi L Copeptin stimulation by combined intravenous arginine and oral LevoDopa\/Carbidopa in healthy short children and children with the Polyuria-Polydipsia syndrome. Horm Res Paediatr May 3 2024:1\u201311. https:\/\/doi.org\/10.1159\/000539208","DOI":"10.1159\/000539208"},{"key":"1523_CR30","doi-asserted-by":"publisher","unstructured":"Atila C, Gaisl O, Vogt DR, Werlen L, Szinnai G, Christ-Crain M (2022) Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study. Eur J Endocrinol 187(1):65\u201374. PMID: 35521789. https:\/\/doi.org\/10.1530\/EJE-22-0033","DOI":"10.1530\/EJE-22-0033"},{"key":"1523_CR31","doi-asserted-by":"publisher","unstructured":"Atila C, Lustenberger S, Chifu I, Ferrante E, Erlic Z, Drummond JB, Indirli R, Drexhage R, Powlson AS, Gurnell M, Santana Soares B, Hofland J, Beuschlein F, Fassnacht M, Winzeler B, Refardt J, Christ-Crain M (2025) Relationship between plasma urea and copeptin in response to arginine stimulation in healthy adults, patients with vasopressin deficiency and primary polydipsia. Pituitary 28(1):18.  PMID: 39863827; PMID: PMC11762438. https:\/\/doi.org\/10.1007\/s11102-024-01489-7","DOI":"10.1007\/s11102-024-01489-7"},{"key":"1523_CR32","doi-asserted-by":"publisher","unstructured":"Lustenberger S, Atila C, Baumgartner J, Monnerat S, Beck J, Santos de Jesus J, Christ-Crain M (2025) Urea-stimulated copeptin: a novel diagnostic approach in polyuria polydipsia syndrome. Eur J Endocrinol 192(4):437-444. PMID: 40168516. https:\/\/doi.org\/10.1093\/ejendo\/lvaf058","DOI":"10.1093\/ejendo\/lvaf058"},{"key":"1523_CR33","doi-asserted-by":"publisher","unstructured":"Varaldo E, Bioletto F, Cuboni D, Prencipe N, Bona C, Barale M, Ghigo E, Grottoli S, Berton AM, Gasco V (2023) Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. Eur J Endocrinol 188(3):lvad019. PMID: 36757796. https:\/\/doi.org\/10.1093\/ejendo\/lvad019","DOI":"10.1093\/ejendo\/lvad019"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01523-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:21:09Z","timestamp":1751397669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01523-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01523-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"8 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}